Patents Assigned to Bar-Ilan Research & Development Co., Ltd.
  • Patent number: 6030961
    Abstract: This invention relates to compositions for and methods of treating, preventing or ameliorating cancer and other proliferative diseases as well as methods of inducing wound hearing, treating cutaneous ulcers, treating gastrointestinal disorders, treating blood disorders such as anemias, immunomodulation, enhancing recombinant gene expression, treating insulin-dependent patients, treating cystic fibrosis patients, inhibiting telomerase activity, treating virus-associated tumors, especially EBV-associated tumors, modulating gene expression and in particular, augmenting expression of tumor suppressor genes, inducing tolerance to antigens, treating, preventing or ameliorating protozoan infection, or inhibiting histone deacetylase in cells. The compositions of the invention are to and the methods of the invention use oxyalkalene phosphate compounds.
    Type: Grant
    Filed: March 11, 1997
    Date of Patent: February 29, 2000
    Assignees: Bar-Ilan Research & Development Co., Ltd., Mor Research Applications Ltd.
    Inventors: Abraham Nudelman, Ada Rephaeli